ACC Recommendations on the Role of Nonstatin Therapies for Lowering LDL-C
In 2021, an expert panel assembled to review gaps in care related to treatments meant to lower LDL-C in patients with atherosclerotic cardiovascular disease.
Atherosclerosis
Statin Use and Recurrent, Terminal Major Adverse Cardiovascular Events
Researchers sought to examine the effect of statin therapy on recurrent major adverse cardiovascular events.
One-Year Restenosis Rates After Fluoropolymer-Based Drug-Eluting Stent Implantation for PAD
A study was done to determine the 1-year risk for aneurysmal degeneration and restenosis following implantation of fluoropolymer-based drug-eluting stents.
Long-Term Safety and Efficacy of Bempedoic Acid for Lowering LDL-C in ASCVD, HeFH
A study was conducted to determine the efficacy and long-term safety of bempedoic acid for treatment of ASCVD and HeFH.
Exploring the Link Between Oral Health and Cardiovascular Disease
Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.
Elevated Lipoprotein(a) and Coronary Artery Calcium Score Linked to ASCVD Risk
Investigators examined the independent and joint association of lipoprotein(a) and coronary artery calcium with risk for atherosclerotic cardiovascular disease.
Breast Arterial Calcification May be a Marker for Atherosclerotic Cardiovascular Disease
A study was conducted to determine the relationship between breast arterial calcification and risk for atherosclerotic cardiovascular disease.
A Proteomics Model for Predicting Recurrent ASCVD Risk Outperforms Clinical Risk Model
Researchers evaluated the ability to improve risk stratification of patients with ASCVD via a novel machine-learning model.
Benefits of Smoking Cessation Quantified in Patients With Atherosclerotic CVD
For patients with established atherosclerotic cardiovascular disease, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers.
Sex-Based Disparities in Atherosclerotic Cardiovascular Disease Care
Radmila Lyubarova, MD, and Michael G. Nanna, MD, discuss the lack of awareness regarding risk for ASCVD in women and disparities in treatment that they face.
- Loading...
Loading...
Next post in Cardiovascular and Metabolic Disorders
Loading... 
Loading...